ArticleNeoplasia (New York, N.Y.)2008

A functionally significant cross-talk between androgen receptor and ErbB2 pathways in estrogen receptor negative breast cancer.

Ali Naderi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.